The UPC Court of Appeal has validated Amgen’s PCSK9 antibody patent and clarified its inventive step and medical-use claim approach, bringing UPC practice closer to the EPO.
With the UPC gaining traction, challengers now weigh EPO oppositions alongside UPC revocations. Parallel proceedings offer tactical advantages to pressure patentees and boost invalidation success.
In Washtower v BEGA, the UPC applied the Plant-e equivalence test to grant a preliminary injunction, showing its willingness to find likely infringement beyond literal claim scope.
The UPC’s competence over pending European patent applications remains unclear - but the impact on opt-outs could be significant. We explore risks, rules and practical takeaways for applicants.
The UPC has been open for two years. We bust common myths and misconceptions about the Unified Patent Court and Unitary Patent system, with practical insights and updates from our experts.
The UPC’s Court of First Instance confirms the EPO’s problem-and-solution approach as the main method for assessing inventive step, ensuring consistency and legal certainty across Europe.
The UPC now has confirmed authority over pre-UPCA infringements, even during opt-out periods. This landmark decision reshapes jurisdiction expectations.
The UPC ruling highlights the importance of timely action for provisional measures, stressing quick evidence gathering and adherence to procedural rules for patent claims.
When requesting unitary effect for a granted European patent, the request for unitary effect must also contain a translation of the European patent. In
